IRB News September 2025

/in /by

Want to stay informed of the latest UC Davis Institutional Review Board news? Subscribe to the IRB listserv.

Can’t Catch Us Slipping

The FDA recently completed its audit of our IRB, and the outcome was as good as it gets: no findings and no recommendations. This result reflects the dedication of our team, the strength of our processes, and our shared commitment to protecting the rights and welfare of participants involved in research conducted under the auspices of UC Davis.

ICH E6 the (R3)mix: Staying in Tune with GCP Training Requirements

Join us on Thursday, September 11, from 12:00 PM to 1:00 PM for a virtual “lunch and learn” where will introduce new Good Clinical Practice (GCP) training requirements at UC Davis. Participants will learn which GCP training courses have been updated to reflect ICH’s new Guideline for Good Clinical Practice E6(R3) and how to remain compliant with institutional and sponsor training requirements.

Learning Objectives

  1. Recognize the GCP training course options available to UC Davis researchers.
  2. Identify which GCP training courses meet institutional and sponsor requirements.
  3. Explain the process for determining which GCP training course applies to a given study.

Registration Link

Compensation, No Cap

We have updated the

We have updated the Candex Participant Information Sheet to let participants know that study payments issued through Candex are no longer capped at $1,500 per calendar year. As a reminder, this information sheet is available on our IRB Forms webpage and does not need to be submitted to the UC Davis IRB for approval prior to use.

2026: A Scheduling Odyssey

Thinking ahead? So is HAL are we. The 2026 IRB Meeting Dates are now posted on our About IRB webpage. Take a peek at the year ahead. The future of research starts with a good calendar.

 

FAQs

Why did the IRB ask me to separate my combined modification and reportable event package?

Submitting unrelated reportable events and modifications in the same package can slow down the review process because each type of submission may require a different level of review. To prevent delays, we now ask researchers to submit unrelated reportable events and modifications as separate packages.

What email should I use to contact the IRB? What about the Reliance Team?

For general questions, please email [email protected]. To contact the Reliance Team, please email [email protected]. We are not going to migrate to the @health.ucdavis.edu domains.

How do I get added to this incredible listserv?

Subscribe here.